Myasthenia Gravis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have muscle weakness that comes and goes, affecting muscles such as those controlling your eyes, swallowing, speaking, or moving your limbs — and this weakness tends to be worse in the morning and gets better with rest, but worse with continued activity.
- You (or your legal guardian, if applicable) are able to understand and sign a consent form agreeing to take part.
- At least one of the following also applies to you:
- A special test called a "Tensilon test" (a medication test used to check for this type of muscle weakness) came back positive.
- Nerve and muscle tests showed specific abnormal patterns, such as a drop in muscle electrical response during repeated nerve stimulation, or unusual timing variations detected during a single-fiber muscle test (confirm with trial site).
- A blood test showed the presence of certain antibodies linked to this condition (called AChR, MuSK, or LRP4 antibodies).
Who may not be able to join:
- People who have a mental health condition that would prevent them from cooperating with the study.
- People who have serious problems with multiple organs or are in a very critical medical state, making it impossible to complete the necessary assessments and medical history collection.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 86 2152889999
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
MSE proportion
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.